Working at the intersection of investment and commercialization, Elizabeth Jennings is known for bringing innovative technologies to commercial success. Focused on healthcare, life science, and social impact, she runs portfolio services firm Venture Atlas Labs, through which she and the VAL team focus on developing successful commercial and market scenarios for international trade organizations, venture capital, private equity, and corporate units. Leveraging experience launching new scientific and medical technologies in some of the most complex and challenging markets worldwide, she frequently speaks at accelerators, institutes, and global summits on fundraising and commercial strategy.
As a board member of the SWAN Impact Network, the fastest growing social impact angel network in the US, she aims to maximize the success of for-good startups. She also serves on the Texas Global Health Security Innovation Consortium, the World Affairs Council, federal grant review committees, with the National Science Foundation I-Corps, and as an advisor and a board member for a handful of medical device, in-vitro diagnostics, and AI startups. She supports a number of organizations addressing critical international development and neglected tropical disease issues.
With nearly a decade living in South America and Europe, she speaks Spanish and Italian reasonably well, and Portuguese, French, and Dutch with good intentions.
